|
Nature Medicine Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine on the basis of its originality, timeliness, interdisciplinary interest and impact on improving human health. Nature Medicine also publishes commissioned content, including News, Reviews and Perspectives, aimed at contextualizing the latest advances in translational and clinical research to reach a wide audience of M.D. and Ph.D. readers. |
|
Nature Aging Nature Aging’s mission is to provide a unique multidisciplinary, unifying and highly visible publishing platform for the aging-research community. The journal is highly selective yet broad in its coverage, publishing research from across the entire spectrum of the field, ranging from the basic biology of aging to the impact of aging on society. The journal aims to foster interactions among different areas of this diverse field of research and to promote new and exciting ideas within and beyond the research community, to enable synergy and maximize scientific and societal impact. |
|
Communications Medicine Communications Medicine is a selective open access journal from Nature Portfolio publishing high-quality research, reviews and commentary across all clinical, translational and public health research fields. Primary research papers published by the journal represent significant advances in preventing, diagnosing or treating human disease of relevance to a specialized field. The journal is equally interested in publishing in well-established as well as emerging areas of medicine and public health. |
|
Nature Communications Nature Communications is an open access journal that publishes high-quality research from all areas of the natural sciences. Papers published by the journal represent important advances of significance to specialists within each field. Nature Communications has a 2-year impact factor: 16.6 (2022), article downloads of 99,089,239 (2022) and 8 days (median) from submission to the first editorial decision. |
|
Davos Alzheimer's Collaborative DAC’s focus is on scaling brain health research to drive new innovations, accelerating precision treatments through the global clinical trial infrastructure without sacrificing quality, and equipping healthcare systems to improve individual lives today and in the future. DAC is leading the largest global response of its kind on dementia and Alzheimer’s, driving scientific discovery and aligning health systems to help people worldwide, including those in low- and middle-income resource settings left out of previous efforts to fight Alzheimer’s. DAC’s focus is to drive progress in three critical areas:
- Developing a global cohort to diversify the populations we can reach with targeted treatments.
- Creating a global clinical trial platform to reduce the cost and time of developing new treatments.
- Preparing every healthcare system to deliver Alzheimer’s care and speed innovations to those who need them most.
|
|
The AGA Khan University The Brain and Mind Institute (BMI) at the Aga Khan University, operates in East Africa and Central/South Asia. BMI’s ethos is to span from neuron to the neighborhood, and across multi-country campuses. The operational model is to empower and strengthen neuroscience and mental health research and interventions through capacity building and partnerships; connecting the rich tapestry of academics, research entities, stakeholders, and communities of lived experience.
BMI facilitates interdisciplinary research, education and innovation in mental health and neurosciences. Through transdisciplinary research approaches, BMI aims to impact the lives of people who are affected by debilitating neurological and mental health problems. Whether it is uncovering the causes of illness or advancing breakthrough research into treatments or interventions, BMI’s approach is always mindful of the local needs of the people and communities at risk. |